Non-Profit Trusted Source of Non-Commercial Health Information
The Original Voice of the American Academy of Anti-Aging, Preventative, and Regenerative Medicine
logo logo
Cancer

Bombshell: Northwestern University Killed Cancer Cells in 2-3 Days

6 years, 4 months ago

18253  3
Posted on Nov 21, 2017, 9 a.m.

A recently published article in the Journal of Nature Biomechanical Engineering discusses how altering the chromatin structure in cancer cell may make them more vulnerable to destruction.

“This is a big breakthrough in the fight to eradicate Cancer!! If we can minimize or eliminate the use of Chemotherapy and other toxic elements introduced to the human body by combining a Pain Reliever, and a Heart medication, the healthcare industry has really made a giant leap in the fight against Cancer. The question is if more people are really dying faster by using Mainstream Chemo Protocol, why is Chemo still the go to Quarterback directing the offense? The fact that Tom Brady is an Anti-Aging miracle playing at the top of the NFL game at 40 is remarkable, but if Tom Brady wasn’t effective, they would pull him for someone new. We need to look at more alternatives in the battle against Cancer faster and more aggressively. By the numbers alone, just Chemotherapy is not working,” said Dr. Ronald Klatz, President of the A4M.

A recently published article in the Journal of Nature Biomechanical Engineering discusses how altering the chromatin structure in cancer cell may make them more vulnerable to destruction. Up until now cancer cells have been known to be extraordinarily sturdy and difficult to destroy. This new finding holds great promise for the future in destroying cancer cells and is already killing off cancer cells in lab cultures. 

Chromatin is a key element in the cell nucleus and DNA structure. Histone (a protein) is at the center of DNA molecules in the nucleus. In normal cells, Chromatin helps to pack the DNA code into the cell nucleus, and then helps to regulate the activity of genes, telling them when to activate and when not to activate. However, in cancer cells, Chromatin protects the cancer cell from otherwise destructive chemo-therapy by helping the bad cells to adapt and resist the attack.

Vadim Backman, of the McCormick School of Engineering at Northwestern University in Evanston, IL explains that in today’s digital age, genetics are like computer hardware and the chromatin is like software, reprogramming and adapting as it goes along.

Backman and his colleagues have developed an imaging technique to increase their knowledge about this complex system called Partial Wave Spectroscopic (PWS) microscopy. PWS allows for monitoring chromatin behavior in living cells. Cancer cells interact with chromatin at a specific point of 20-200 nanometers, which is now visible by means of the PWS system. They were able to ascertain that chromatin’s variable “packing density” is responsible for cancer cells fighting off certain cancer treatments. Therefore, an ordered packing density promoted cancer cell death while a random order kept them alive. The PWS allowed the researchers to determine the packing density and determine which cells would live and which ones would die.

They reasoned that by organizing the structure of the chromatin they could defeat cancer cells more quickly and easily. They found that reorganization could be achieved through the alteration of interior nucleus electrolytes in the cancer cell. In order to achieve this outcome, they used a combination of two FDA approved drugs, Celecoxib (a pain reliever) and Digoxin (a heart medication). When combined they’re called “chromatin protection therapeutics” or CPTs. When CPTs are combined with regular chemotherapy, all of the cancer cells died within 2-3 days.

Despite this remarkable leap in therapeutics, the authors of the study caution much more research is needed on both animals and humans, as these experiments were performed in controlled studies in the lab. Humans and animals are very complex and may have hundreds of variables or side-effects.

Sources:

 Nature Biomedical Engineering (2017)

doi:10.1038/s41551-017-0153-2

www.researchoncology.com

Honor Whiteman

By: Dr. Michael J. Koch, Editor for www.WorldHealth.net and Dr. Ronald Klatz, DO, MD President of the A4M which has 28,000 Physician Members, and has trained over 150,000 physicians, health professionals and scientists around the world in the new specialty of Anti-Aging Medicine. A4M physicians are now providing advanced preventative medical care for over 10’s of Million individuals worldwide who now recognize that aging is no longer inevitable.

WorldHealth Videos